PL373543A1 - Kompozycja farmaceutyczna zawierająca biosyntetyczny analog insuliny ludzkiej, oraz jej zastosowanie w terapii cukrzycy - Google Patents

Kompozycja farmaceutyczna zawierająca biosyntetyczny analog insuliny ludzkiej, oraz jej zastosowanie w terapii cukrzycy

Info

Publication number
PL373543A1
PL373543A1 PL373543A PL37354305A PL373543A1 PL 373543 A1 PL373543 A1 PL 373543A1 PL 373543 A PL373543 A PL 373543A PL 37354305 A PL37354305 A PL 37354305A PL 373543 A1 PL373543 A1 PL 373543A1
Authority
PL
Poland
Prior art keywords
well
application
compound containing
human insulin
pharmaceutical compound
Prior art date
Application number
PL373543A
Other languages
English (en)
Inventor
Piotr Borowicz
Jerzy Mikołajczyk
Monika Bogiel
Henryk Klukowski
Anna Krejer
Original Assignee
Instytut Biotechnologii i Antybiotyków
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Instytut Biotechnologii i Antybiotyków filed Critical Instytut Biotechnologii i Antybiotyków
Priority to PL373543A priority Critical patent/PL373543A1/pl
Priority to PCT/PL2006/000016 priority patent/WO2006096079A2/en
Publication of PL373543A1 publication Critical patent/PL373543A1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
PL373543A 2005-03-10 2005-03-10 Kompozycja farmaceutyczna zawierająca biosyntetyczny analog insuliny ludzkiej, oraz jej zastosowanie w terapii cukrzycy PL373543A1 (pl)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PL373543A PL373543A1 (pl) 2005-03-10 2005-03-10 Kompozycja farmaceutyczna zawierająca biosyntetyczny analog insuliny ludzkiej, oraz jej zastosowanie w terapii cukrzycy
PCT/PL2006/000016 WO2006096079A2 (en) 2005-03-10 2006-03-09 Pharmaceutical composition comprising a biosynthetic analog of human insulin, and its use in the treatment of diabetes mellitus.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL373543A PL373543A1 (pl) 2005-03-10 2005-03-10 Kompozycja farmaceutyczna zawierająca biosyntetyczny analog insuliny ludzkiej, oraz jej zastosowanie w terapii cukrzycy

Publications (1)

Publication Number Publication Date
PL373543A1 true PL373543A1 (pl) 2006-09-18

Family

ID=36953765

Family Applications (1)

Application Number Title Priority Date Filing Date
PL373543A PL373543A1 (pl) 2005-03-10 2005-03-10 Kompozycja farmaceutyczna zawierająca biosyntetyczny analog insuliny ludzkiej, oraz jej zastosowanie w terapii cukrzycy

Country Status (2)

Country Link
PL (1) PL373543A1 (pl)
WO (1) WO2006096079A2 (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL219335B1 (pl) * 2008-07-04 2015-04-30 Inst Biotechnologii I Antybiotyków Pochodna insuliny lub jej farmaceutycznie dopuszczalna sól, jej zastosowanie oraz zawierająca ją kompozycja farmaceutyczna
PL222975B1 (pl) 2012-05-23 2016-09-30 Inst Biotechnologii I Antybiotyków Analog insuliny lub jego farmaceutycznie dopuszczalna sól, kompozycja farmaceutyczna o przedłużonym działaniu terapeutycznym oraz zastosowanie analogu insuliny

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3327709A1 (de) * 1983-07-29 1985-02-07 Hoechst Ag, 6230 Frankfurt Insulin-derivat-kristallsuspensionen, verfahren zu deren herstellung und deren verwendung
DE3844211A1 (de) * 1988-12-29 1990-07-05 Hoechst Ag Neue insulinderivate, verfahren zu deren herstellung, ihre verwendung und eine sie enthaltende pharmazeutische zubereitung
US6451970B1 (en) * 1996-02-21 2002-09-17 Novo Nordisk A/S Peptide derivatives
CO4970787A1 (es) * 1997-12-23 2000-11-07 Lilly Co Eli Composiciones insolubles de insulina y derivados de insulina que controlan la glucosa sanguinea

Also Published As

Publication number Publication date
WO2006096079A3 (en) 2007-03-22
WO2006096079A2 (en) 2006-09-14

Similar Documents

Publication Publication Date Title
IL184838A0 (en) Spiroketal derivative and use thereof as diabetic medicine
IL185462A0 (en) New pharmaceutical compositions useful in the treatment of pain
IL185277A0 (en) Pharmaceutical compositions containing roflumilast for the treatment of diabetes
IL195947A (en) Manicured cyclic compounds and pharmaceutical preparations containing them for use @ for prevention @ and treatment @ for diabetes
WO2007128817A3 (en) Insulin derivative
IL185761A0 (en) Pharmaceutical compositions for treating diabetes
IL225198A (en) Aminotetrahydropyrenic Compounds, Pharmaceutical Preparations Containing Them and Their Use in the Treatment of Diabetes
PL381247A1 (pl) Skondensowana pochodna heterocykliczna, zawierająca ją kompozycja lecznicza, oraz jej zastosowanie lecznicze
EP2048153A4 (en) SUBSTITUTED SPIROCETAL DERIVATIVE AND USE THEREOF AS A MEDICAMENT IN THE TREATMENT OF DIABETES
HK1113289A1 (en) Composition for nutritionally improving glucose control and insulin action
GB0522311D0 (en) Pharmaceutical compositions for the treatment of pain
IL196869A0 (en) A pharmaceutical composition containing a hexahydrophenanthridin-2-ol derivative in combination with another active ingredient for treatment of diabetes mellitus
HK1098700A1 (en) Use of drug combinations for treating insulin resistance
ZA200708327B (en) Reduction of postoperative pain medication
EP2100610A4 (en) PHARMACEUTICAL COMPOSITION WITH LOW SUBSTITUTED HYDROXYPROPYL CELLULOSE
EP2070540A4 (en) DRUG COMPOSITION FOR THE TREATMENT OF DIABETES TYPE 2 AND CHRONIC NEOPATHY
HK1120234A1 (en) Medical composition for promotion of skin regeneration
HK1100484A1 (en) Application of n-butylidenephthalide in preparing cancer treatment medication
EP1872815A4 (en) SUBCUTANEOUS INSULIN THERAPY WITH PERFUSION CONTINUES
HUE048806T2 (hu) Inzulin kristályos, valamint szolubilizált formáját tartalmazó gyógyászati készítmény
EP1889618A4 (en) COMBINED MEDICINE FOR THE TREATMENT OF DIABETES
EP2322207A4 (en) OXYGEN TRANSMITTING BLOOD SUBSTITUTE AND PHARMACEUTICAL COMPOSITION (VARIANTS)
IL184697A (en) Diclofenac Injection Composition, Process for its Preparation and Use for Medication and Pain Relief and / or Inflammation
EP1792620A4 (en) MEDICAL COMPOSITION WITH AN AGENT AGAINST DIABETES
PL373543A1 (pl) Kompozycja farmaceutyczna zawierająca biosyntetyczny analog insuliny ludzkiej, oraz jej zastosowanie w terapii cukrzycy

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)